Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 268 results for "zydus group"

Zydus Cadila gets USFDA nod for kidney stones tablets
Money Control

Zydus Cadila gets USFDA nod for kidney stones tablets

The group currently has 94 approvals and has so far filed 239 abbreviated new drug applications (ANDA), Cadila Healthcare said. Money Control, 2 months ago
Zydus gets USFDA tentative nod for diabetic tablets Press Trust of India, 1 month ago
[x]  

Stock Prices as on Oct 16, 2014

GROUP A A A B B 1013.55(1055.7) 1263-540 (7) A C C 1377.85(1383.5) 1570-971 (17) Abbot 3034.9(3058.4) 3462-1305 (1) Abg Shipyard 222.3(233.55) 327-210 (31) Abirlanuv 1593.0(1636.0) 1738-1030 (8) Acl 205.35(208.55) 243-150 (70) Adani Enter 444.2(452.95) ...
 Deccan Herald4 days ago

Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research

Firstcall Research report on Cadila Healthcare Zydus Cadila, a global healthcare provider was founded by Late Mr. Ramanbhai B. Patel in 1952. In 1995, the group restructured its operations and emerged with a new identity under the aegis of Zydus ...
 Moneycontrol.com2 weeks ago Cadila Healthcare jumps after USFDA OK for anti-viral drug  Capital Market2 months ago

Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C

Zydus and Gilead Sciences, Inc. have signed a non-exclusive licensing agreement which will allow the generic manufacture of sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir for distribution in 90 developing ...
 Equity Bulls1 month ago Zydus granted license to produce generic hepatitis C drug  Smart Investor1 month ago Zydus gets Gilead licence for Hepatitis C treatment  Hindu Business Line1 month ago

NPPA price control buzz positive for Sanofi, Zydus, Ranbaxy:Angel Broking

The National Pharmaceutical Pricing Authority (NPPA) has withdrawn guidelines for price control of 108 formulations, which was issued under Para, 19 of the drug prices control order (DPCO). NPPA had capped prices of 108 cardiac and diabetes drugs on ...
 MyIris3 weeks ago Industry hails move  The Hindu3 weeks ago
Business Standard India

Zydus Cadila bags license for hepatitis C drug

medabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc, which will allow the generic manufacture of sofosbuvir and ledipasvir (used for treatment of ...
 Business Standard India1 month ago

Zydus Cadila Q1 Net profit up by 23%

, Zydus Cadila reported sales of Rs. 2057 crore, up by 25% from Rs. 1646 crore in the corresponding quarter of the previous year on a consolidated basis. The net profit is up by 23% to Rs. 240 crore from Rs. 195 crore in the first quarter of ...
 Noodls2 months ago CADILA HEALTHCARE : Zydus Cadila Q1 Net profit up by 23%  4 Traders2 months ago

Decontrolling Drug Prices

, the National Pharmaceutical Pricing Authority (NPPA) withdrew at the behest of the central government, which was bowing to the pressure from drug companies, its July 10 order capping the prices of 108 life-saving drugs. These drugs are essential ...
 Peoples Democracy.in3 days ago Drug price decontrol will hit cardiac, diabetic patients hard  DNA India3 weeks ago

Osteoporosis & Osteoarthritis Therapeutic Pipeline Review (Company & Drugs Profile) H2 2014 in a New Report Available at RnRMarketResearch.com

This report provides comprehensive information on the therapeutic development for Osteoarthritis & Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...
 Digital Journal3 days ago
[x]  
Financial Express

Cadila Healthcare recalls anti-hypertension drug in US

Drug firm Cadila Healthcare is voluntarily recalling 5,400 bottles of anti-hypertension drug Atenolol tablets, in the U.S. for failing to meet specifications. According to a notification by the US Food and Drug Administration (USFDA), the recall ...
 Hindu Business Line3 days ago Cadila Healthcare recalls blood pressure drug in the US  Business Standard India3 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less